THE RELATIONSHIP OF THE DEGREE OF IMPAIRMENT OF THE STRUCTURE AND FUNCTION OF THE LIVER WITH ITS CHRONIC ILLNESSES IN CHILDREN

Cover Page
  • Authors: Volynets G.V.1, Evlukhina N.N.1, Filin A.V.2, Potapov A.S.1, Dvoryakovskii I.V.1, Dvoryakovskaya G.M.1, Surkov A.N.1, Shavrov A.A.3, Pakhomovskaya N.L.1, Skvortsova T.A.1
  • Affiliations:
    1. Scientific Centre of Children Health, Moscow, Russian Federation
    2. Petrovsky Russian Research Centre of Surgery, Moscow, Russian Federation
    3. Research Institute for Emergency Pediatric Surgery and Traumatology, Moscow, Russian Federation
  • Issue: Vol 70, No 2 (2015)
  • Pages: 203-213
  • Section: PEDIATRICS: CURRENT ISSUES
  • URL: https://vestnikramn.spr-journal.ru/jour/article/view/57
  • DOI: https://doi.org/10.15690/vramn.v70i2.1314
  • Cite item

Abstract


Objective: Our aim was to on the basis of determining the degree of violation of the structure and function of the liver establish their relationships and to assess the dynamics of liver disease in its chronic illnesses in children. Methods: With the help of the developed scoring systems were used to assess the degree of liver dysfunction and the degree of disruption of the structure of the liver and the severity of portal hypertension. Results: The results of the diagnostic methods 252 children aged 1 to 17 years (mean age of 11.8±3,5) with Wilson disease (WD), autoimmune hepatitis (AIH), chronic hepatitis C (CHC) were analyzed; 48 patients underwent liver transplantation. In children with WD, AIH and CHC liver function reduced by 41.3±12.9 % to 28.8±12.5% and 19.1±7.8% respectively. Structure of the liver in children with WD, AIH and CHC was disturbed by 25.0±8.1% to 20.4±9.2% and 6.8±4.4% respectively. The function and structure violations of the liver more pronounced in liver cirrhosis. The use of the developed scoring systems to monitor the severity of liver damage in the dynamics and evaluation of the effectiveness of the therapy is demonstrated. The degree of liver dysfunction is directly dependent on the degree of its structure. Abnormal liver function ≥40% and ≥40% of its structure with treatment failure can be used as a criterion of indications for elective liver transplantation with its chronic diseases in children. Conclusion: Developed a point system to determine liver function and a point system to determine disruption of the structure of the liver and the severity of portal hypertension in children can serve as an objective criterion for assessing the severity of liver disease, monitoring their changes in the dynamics with the assessment of the effectiveness of the therapy and making decisions about the need for routine liver transplantation in its chronic illnesses in children.

 


G. V. Volynets

Scientific Centre of Children Health, Moscow, Russian Federation

Author for correspondence.
Email: volynec_g@mail.ru

Russian Federation

доктор медицинских наук, главный научный сотрудник гастроэнтерологического отделения с гепатологической группой Научного центра здоровья детей
Адрес: 119991, Москва, Ломоносовский пр-т, д. 2, стр. 1, тел.: +7 (499) 134-06-97

N. N. Evlukhina

Scientific Centre of Children Health, Moscow, Russian Federation

Email: gnatenko.n.n@mail.ru

Russian Federation

аспирант гастроэнтерологического отделения с гепатологической группой Научного центра здоровья детей
Адрес: 119991, Москва, Ломоносовский пр-т, д. 2, стр. 1, тел.: +7 (499) 134-06-97

A. V. Filin

Petrovsky Russian Research Centre of Surgery, Moscow, Russian Federation

Email: docfilin@inbox.ru

Russian Federation

доктор медицинских наук, заведующий отделением пересадки печени РНЦХ
Адрес: 119991, Москва, Абрикосовский пер., д. 2, тел.: +7 (499) 766-47-31

A. S. Potapov

Scientific Centre of Children Health, Moscow, Russian Federation

Email: potapov@nczd.ru

Russian Federation

доктор медицинских наук, профессор, заведующий гастроэнтерологическим отделе-
нием с гепатологической группой Научного центра здоровья детей
Адрес: 119991, Москва, Ломоносовский пр-т, д. 2, стр. 1, тел.: +7(499) 134-06-97

I. V. Dvoryakovskii

Scientific Centre of Children Health, Moscow, Russian Federation

Email: dvor09@yandex.ru

Russian Federation

доктор медицинских наук, профессор, заведующий отделением ультразвуковой диагностики Научного центра здоровья детей
Адрес: 119991, Москва, Ломоносовский пр-т, д. 2, стр. 1, тел.: +7 (499) 132-26-01

G. M. Dvoryakovskaya

Scientific Centre of Children Health, Moscow, Russian Federation

Email: dvoryakovskay@nczd.ru

Russian Federation

кандидат медицинских наук, старший научный сотрудник отделения ультразвуковой диагностики Научного центра здоровья детей
Адрес: 119991, Москва, Ломоносовский пр-т, д. 2, стр. 1, тел.: +7 (499) 132-26-01

A. N. Surkov

Scientific Centre of Children Health, Moscow, Russian Federation

Email: surkov@nczd.ru

Russian Federation

кандидат медицинских наук, врач-гастроэнтеролог отделения восстановительного
лечения детей с болезнями органов пищеварительной системы Научного центра здоровья детей
Адрес: 119991, Москва, Ломоносовский пр-т, д. 2, стр. 1, тел.: +7 (499) 134-01-57

A. A. Shavrov

Research Institute for Emergency Pediatric Surgery and Traumatology, Moscow, Russian Federation

Email: Shavrovaa@yandex.ru

Russian Federation

доктор медицинских наук, ведущий научный сотрудник отделения гнойной хирургии НИИ неотложной детской хирургии и травматологии
Адрес: 119180, Москва, ул. Большая Полянка, д. 22, тел.: +7 (495) 959-51-20

N. L. Pakhomovskaya

Scientific Centre of Children Health, Moscow, Russian Federation

Email: chexonte76@mail.ru

Russian Federation

кандидат медицинских наук, научный сотрудник гастроэнтерологического отделения с гепатологической группой Научного центра здоровья детей
Адрес: 119991, Москва, Ломоносовский пр-т, д. 2, стр. 1, тел.: +7 (499) 134-06-97

T. A. Skvortsova

Scientific Centre of Children Health, Moscow, Russian Federation

Email: skvortcova.tamara@yandex.ru

Russian Federation

аспирант гастроэнтерологического отделения с гепатологической группой Научного центра здоровья детей
Адрес: 119991, Москва, Ломоносовский пр-т, д. 2, стр. 1, тел.: +7 (499) 134-06-97

  1. Lurie J.E., Metelin A.V., Kuznetsova A.E. Modern forecasting models survival in patients with end-stage liver disease. Klinicheskaya i eksperimental'naya khirurgiya. Zhurnal im. akad. B.V. Petrovskogo = Clinical and experimental surgery. Academician B.V. Petrovsky journal. 2014; 2: 48–58.
  2. Dehghani S.M., Gholami S., Bahador A., Haghighat M., Ima-nieh M.H., Nikeghbalian S. et al. Comparison of Child–TurcottePugh and pediatric end-stage liver disease scoring systems to predict morbidity and mortality of children awaiting liver transplantation. Transplant. Proc. 2007; 39 (10): 3175–3177.
  3. Shiff Yu.R., Sorrel M.F., Meddrei U.S. Tsirroz pecheni i ego oslozhneniya. Transplantatsiya pecheni [Cirrhosis and its Complications. Liver Transplantation]. Moscow, GEOTAR-Media, 2012. 592 p.
  4. Rajanayagam J., Coman D., Cartwright D., Lewindon P.J. Pediatric acute liver failure: etiology, outcomes, and the role of serial pediatric end-stage liver disease scores. Pediatr. Transplant. 2013; 17 (4): 362–368.
  5. Freeman R.B., Harper A., Edwards E.B. Excellent liver transplant survival rates under the MELD / PELD system. Transplant. Proc. 2005; 37 (2): 585–588.
  6. Squires R.H., Ng V., Romero R., Ekong U., Hardikar W., Emre S., Mazariegos G.V. Evaluation of the Pediatric Patient for Liver Transplantation: 2014 Practice Guideline by the American Association for the Study of Liver Diseases, American Society of Transplantation and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Hepatology. 2014; 60 (1): 362–398.
  7. International Classification of Functioning, Disability and Health. Geneva, WHO, 2001. 342 p.
  8. World Health Organization. International Classification of Functioning, Disability and Health: Child and youth version. Geneva: World Health Organization. 2007. 322 p.
  9. Mabrouk M., El-Raziky M., Zayed N., Salama R., El-Akel W., Awad T. et al. Clinical, biochemical and pathological profiles of 5464 Egyptian chronic hepatitis C-infected patients. Hepatogastroenterology. 2013; 60 (127): 1731–1735.
  10. Guechot J., Boisson R.C., Zarski J.P., Sturm N., Cales P., Lasnier E. et al. AST/ALT ratio is not an index of liver fibrosis in chronic hepatitis C when aminotransferase activities are determinate according to the international recommendations. Clin. Res. Hepatol. Gastroenterol. 2013; 37 (5): 467–472.
  11. Aktug Demir N., Kolgelier S., Ozcimen S., Gungor G., Sumer S., Saltuk Demir L. et al. Evaluation of the relation between hepatic fibrosis and basic laboratory parameters in patients with chronic hepatitis B fibrosis and basic laboratory parameters. Hepat. Mon. 2014; 14 (4): 16975.
  12. Volynets G.V., Potapov A.S., Polyakova S.I., Aleksandrov A.E., Senyakovich V.M., Surkov A.N., Chetkina T.S., Evlyukhina N.N., Skvortsova T.A. Determining the degree of liver dysfunction in children. Voprosy sovremennoi pediatrii = Current pediatrics. 2013; 4: 47–51.
  13. Volynets G.V., Evlyukhina N.N., Filin A.V., Potapov A.S., Shavrov A.A., Dvoryakovskii I.V., Surkov A.N., Anikin A.V., Zelikovich E.I. Violation of the structure of the liver and severe portal hypertension in children based on the International Classification of Functioning, Disability and Health. Vestnik Vserossiiskogo obshchestva spetsialistov po mediko-sotsial'noi ekspertize, reabilitatsii i reabilitatsionnoi industrii = Bulletin of the All-Russian Society of medical and social examination, rehabilitation and rehabilitation industry. 2014; 3: 49–60.
  14. Manns M.P., Czaja A.J., Gorham J.D., Krawitt E.L., Mieli-Ver-gani G., Vergani D. et al. American Association for the Study of Liver Diseases. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010; 51 (6): 2193–2213.
  15. European Association for Study of Liver. EASL Clinical Practice Guidelines: Wilson's disease. J. Hepatol. 2012; 56 (3): 671–685.
  16. European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C 2014. J. Hepatol. 2014; 61 (2): 373–395.
  17. Dvoryakovskii I.V. Ul'trazvukovaya anatomiya zdorovogo rebenka [Ultrasound Anatomy of a Healthy Baby]. Moscow, Firma STROM, 2009. 384 p.
  18. Meng F., Zheng Y., Zhang Q., Mu X., Xu X., Zhang H., Ding L. Noninvasive Evaluation of Liver Fibrosis Using Real-time Tissue Elastography and Transient Elastography (FibroScan). J. Ultrasound Med. 2015; 34 (3): 403–410.
  19. Chen Y.P., Liang X.E. Noninvasive Assessment of Liver Fibrosis: Reduce or Substitute the Need for Liver Biopsy? Liver Int. 2015. doi: 10.1111/liv.12824.
  20. Ferraioli G., Tinelli C., Lissandrin R., Zicchetti M., Dal Bello B., Filice G., Filice C. Point shear wave elastography method for assessing liver stiffness. World J. Gastroenterol. 2014; 20 (16): 4787–4796.
  21. Desmet V.J., Gerber M., Hoofnagle J.H., Manns M., Scheuer P.J. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 1994; 19: 1513–1520.
  22. Squires J.E. 50 years ago in the Journal of Pediatrics: needle biopsy of the liver in infants and children. J. Pediatr. 2014; 165 (2): 299.
  23. Shavrov A.A., Pelikh S.T., Klochkov S.A. Changes in the upper digestive tract in chronic liver disease and portal hypertension. Pediatriya = Pediatrics. 1999; 2: 26.
  24. Iorio R., Giannattasio A., Sepe A., Terracciano L.M., Vecchione R., Vegnente A. Chronic hepatitis C in childhood: an 18-year experience. Clin. Infect. Dis. 2005; 41 (10): 1431–1437.
  25. Munir S., Saleem S., Idrees M., Tariq A., Butt S., Rauff B., Hussain A., Badar S., Naudhani M., Fatima Z., Ali M., Ali L., Akram M., Aftab M., Khubaib B., Awan Z. Hepatitis C treatment: current and future perspectives. Virol. J. 2010; 7: 296.
  26. Chetkina T.S. Bolezn' Vil'sona u detei: diagnostika, techenie i prognoz. Avtoref. dis. … kand. med. nauk [Wilson's Disease in Children: Diagnosis, Course and Prognosis. Author’s abstarct]. Moscow, 2004. 24 p.

Views

Abstract - 72

PDF (Russian) - 13

Cited-By


PlumX

Dimensions



Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies